Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Health officials with Goshen Hospital in Indiana called the risk of infection “extremely low.”
The risks are lower than ever—and could save patients months on organ waitlists.
The drug can quickly reverse opioid-driven overdoses.
People who received the vaccine did, however, show stronger immune responses against the virus.
Judge’s ruling may pave the way for opening the nation’s first supervised overdose prevention facility.
Ask Hep answers a question about the risk of transmitting hepatitis C sexually.
Efforts to control viral hepatitis are falling behind, in part because of the growing opioid epidemic and homelessness crisis.
Two new interactive (and free!) databases offer maps, policies and much more, courtesy of amfAR.
The link between diabetes and liver disease
Wider screening would prevent liver cirrhosis, liver cancer and the need for liver transplants.
Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.
A new study appears to resolve controversy over hep C treatment’s association with mortality risk.
Help find the “missing millions” who don’t know they’re living with viral hepatitis.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
This is one of several lawsuits filed by advocates on behalf of inmates with the liver virus in U.S. prisons.
A meta-analysis has helped clear up conflicting previous evidence regarding this association.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.